Anti-Proliferative Deals Proliferate
Executive Summary
Restenosis is a multi-billion dollar market, with the pot of gold waiting for the company that finds a way to keep plaque from building up in coronary arteries. Now some companies are beginning to explore the potential of using anti-proliferative drugs, most notably the now-generic {Taxol}, to help prevent cell proliferation in arteries.